India Urinary Tract Infection Treatment Market Report by Product Type, Indication, End User, State and Company Analysis 2026-2034

Buy Now
Excel: 8 Hours
PDF: 24 Hours
Mar 2026
Pages: 200

FAQs

The India Urinary Tract Infection (UTI) Treatment Market was valued at US$ 392.34 million in 2025 and is expected to reach US$ 526.41 million by 2034, growing at a CAGR of 3.32% from 2026 to 2034.

 

A urinary tract infection is a bacterial infection that affects parts of the urinary system, including the kidneys, bladder, ureters, and urethra. Most UTIs affect the lower urinary tract and can cause pain, burning sensation during urination, and frequent urination.

 

Major growth drivers include:

  • Rising prevalence of urinary tract infections
  • Growing healthcare awareness
  • Expansion of diagnostic facilities
  • Improved healthcare infrastructure
  • Increasing hygiene and sanitation awareness
  • Rising access to healthcare services in urban and semi-urban regions

Women are more susceptible to UTIs due to their shorter urethra, which allows bacteria to reach the bladder more easily. Hormonal changes, pregnancy, sexual activity, and menopause also increase the risk.

 

High-risk groups include:

  • Women
  • Elderly individuals
  • Diabetic patients
  • Pregnant women
  • Patients with catheter use
  • Individuals with weakened immune systems

Common symptoms include:

  • Burning sensation during urination
  • Frequent urge to urinate
  • Cloudy or strong-smelling urine
  • Pelvic pain
  • Fever (in severe infections)
  • Lower abdominal discomfort

Treatment options include:

  • Antibiotics
  • Pain relief medications
  • Antifungal therapies (for fungal infections)
  • Hydration and supportive care
  • Preventive therapies for recurrent infections